| Popis: |
Supa Pengpid,1,2 Manithong Vonglokham,3 Sengchanh Kounnavong,4,5 Vanphanom Sychareun,6 Karl Peltzer7,8 1ASEAN Institute for Health Development, Mahidol University, Salaya, Nakhon Pathom, Thailand; 2Office of the Deputy Vice Chancellor (Research and Innovation), North West University, Potchestroom, South Africa; 3Department of Health Policy and Health System Research, Lao Tropical and Public Health Institute, Vientiane, Laos; 4Lao Tropical and Public Health Institute, Vientiane, Laos; 5Ministry of Health, Vientiane, Laos; 6Faculty of Postgraduate Studies, University of Health Sciences, Ministry of Health, Vientiane, Laos; 7Department for Management of Science and Technology Development, Ton Duc Thang University, Ho Chi Minh City, Vietnam; 8Faculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City, Vietnam Aim: The aim of this study was to determine the national prevalence of hypertension and its awareness, treatment, and control in Laos.Methods: A national cross-sectional study was conducted in 2013. Using stratified cluster random sampling, 2,543 individuals aged 18–64 years were included from Laos. According to WHO STEPS methodology, questionnaire interview, anthropometric and blood pressure measurements, and biochemistry tests were conducted. Logistic regressions were used to estimate the determinants of hypertension (SBP [and/or DBP] ≥140 [90] mmHg or use of antihypertensive medications).Results: Overall, 20.0% of the population had hypertension, 18.5% among men and 21.1% among women. Among hypertensives, 29.4% were aware, 18.2% were currently using antihypertensive medication, and 16.7% had controlled their blood pressure ( |
